Metacam
From Wikipedia, the free encyclopedia
Metacam® is the brand name for the drug Meloxicam intended for veterinary use. It is marketed by Boehringer-Ingelheim; the same company that produces Mobic®, which has the same active ingredient but is intended for human use.
Meloxicam is almost unique as a non-steroidal anti-inflammatory drug or NSAID in veterinary medicine in as much as it is one of the few NSAIDs that is not prone to cause severe stomach ulcers in canines. It is often prescribed after surgery for canine arthritis.
Metacam® is prepared as an injectable solution and an oral suspension (liquid) as opposed to Mobic®, which is produced as tablets. Recently, Boehringer-Ingelheim have introduced palatable Metacam® oral tablets for use mainly as a post-operative analgesic, possibly to compete with Rimadyl (Carprofen).
Metacam® is licensed for use in dogs (injectable and oral forms), but is only licensed in cats in for one-time use in the injectable form because the side effects of repeated doses in cats include acute renal failure and death (as documented in the manufacturer's product sheet for the Metacam® Solution for Injection).
 |
This zoological medicine related article is a stub. You can help Wikipedia by expanding it. |
